| Parkash, Ratika |
| Completed | 4 | 416 | Europe, Canada, US | Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation | John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority | Ventricular Tachycardia (VT) | 06/24 | 06/24 | | |
OCEAN, NCT02168829: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial |
|
|
| Active, not recruiting | 4 | 1284 | Europe, Canada, RoW | Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA | Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc | Atrial Fibrillation, Stroke | 07/25 | 08/25 | | |
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation |
|
|
| Recruiting | 4 | 3018 | Canada | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR) | Atrial Fibrillation | 12/26 | 12/26 | | |
BRAIN-AF, NCT02387229: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF |
|
|
| Terminated | 3 | 1238 | Canada | Rivaroxaban, Xarelto, standard of care | Montreal Heart Institute, Canadian Stroke Prevention Intervention Network, The Montreal Health Innovations Coordinating Center (MHICC), Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, Montreal Heart Institute Foundation, Canadian Institutes of Health Research (CIHR), Hewitt Foundation | ATRIAL FIBRILLATION | 05/24 | 05/24 | | |
ICD-GDMT, NCT04505007: Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes |
|
|
| Active, not recruiting | N/A | 29 | Canada | Specialized heart function clinic | Ratika Parkash, Nova Scotia Health Authority | Heart Failure, ICD | 12/23 | 08/24 | | |
| Recruiting | N/A | 311 | Canada | | Anthony Tang | Atrial Fibrillation, Heart Failure | 09/24 | 09/24 | | |
NCT04599114: Virtual for Care Atrial Fibrillation Patients Using VIRTUES |
|
|
| Not yet recruiting | N/A | 300 | Canada | VIRTUES | Lawson Health Research Institute, Cardiac Arrhythmia Network of Canada | Atrial Fibrillation | 11/23 | 11/24 | | |
RAFT-PermAF, NCT01994252: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation |
|
|
| Active, not recruiting | N/A | 200 | Canada | Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD | Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR) | Heart Disease, Congestive Heart Failure, Atrial Fibrillation | 09/24 | 09/24 | | |
| Recruiting | N/A | 198 | Canada | | Ratika Parkash, Nova Scotia Health Research Fund | Atrial Fibrillation, Paroxysmal or Persistent | 12/26 | 03/27 | | |
| Recruiting | N/A | 670 | Canada | Aggressive Risk Factor Control, Standard of Care | Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Ottawa Heart Institute Research Corporation | Atrial Fibrillation | 12/24 | 12/26 | | |
| Recruiting | N/A | 2554 | Canada | Remote Patient Management, Standard of Care | Ratika Parkash, Cardiac Arrhythmia Network of Canada | Cardiac Arrhythmia | 12/24 | 06/25 | | |
NCT03636230: Remote Patient Management of CIEDs - Brady Devices |
|
|
| Recruiting | N/A | 848 | Canada | Remote Monitoring, Standard of care | Ratika Parkash | Pacemaker | 12/24 | 06/25 | | |
